Med24
overweight-obesity 4. 8. 2026 • 2 min read • Diabetology & metabolic syndrome

Unpacking adiposity: a narrative critical appraisal of diverse obesity definitions

Background Obesity is a complex, multifaceted chronic disease that poses a major global health challenge. Traditionally, population-level screening and follow-up have relied heavily on body mass index (BMI). Although BMI provides a simple, standardized measure for epidemiological studies, it does not account for...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Obesity is a complex, chronic disease presenting a significant global health challenge. Traditionally, population-level screening has relied heavily on body mass index (BMI).

Key Clinical Findings

However, BMI does not account for individual variations in factors such as muscle mass, fat distribution, or metabolic health. Utilizing weight-to-height ratios, even when supplemented with measurements like waist circumference or ratios, offers limited precision in individual diagnosis and comprehensive risk assessment. A more detailed approach is needed to capture the diversity of obesity and enable individualized patient care.

Sponsored content

Obesity Definitions and Assessment

This narrative review examines various obesity definitions, including the World Health Organization classification, the Edmonton Obesity Staging System (EOSS), the Lancet Commission framework, and the European Association for the Study of Obesity framework. BMI remains valuable for population-level assessment and may be useful at the individual level when combined with additional measurements and adjusted cutoff values based on sex, age, and ethnicity. The EOSS expands assessment by incorporating metabolic, physical, psychological, and functional consequences, guiding treatment intensity based on disease severity. The Lancet Commission’s definitions of preclinical and clinical obesity broaden the diagnostic scope but raise concerns regarding the lack of standardized screening tools and potential diagnostic inconsistency. This may be particularly relevant for children and adolescents, where delayed intervention could increase long-term health risks. Weight-history classifications, incorporating maximum weight attained, provide an additional perspective, supporting realistic treatment goals, emphasizing the chronic nature of obesity, reducing stigma, and promoting long-term adherence. No single classification fully represents the biological and clinical heterogeneity of obesity. A combined approach integrating BMI with anthropometric, metabolic, functional, psychological, and weight-history information may improve diagnostic accuracy, risk stratification, and patient-centered obesity care.

Original Scientific Source
Diabetology & metabolic syndrome
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Genetic axes of hand and shoulder soft-tissue disease and their divergent responses to adiposity and incretin therapy: a cross-biobank genomic and randomised trial study
overweight-obesity

Genetic axes of hand and shoulder soft-tissue disease and their divergent responses to adiposity and incretin therapy: a cross-biobank genomic and randomised trial study

Summary Background Hand and shoulder soft-tissue disorders cluster in people with obesity and diabetes, now widely treated with incretin receptor agonists. Whether these disorders share genetic causes, and whether pharmacological weight loss relieves or provokes them, is unknown. Methods We analysed genome-wide data...

28. 10. 2026 Read article →
The interpretation of body-composition metrics in obesity
overweight-obesity

The interpretation of body-composition metrics in obesity

Modern obesity care is increasingly therapeutic, longitudinal, and outcome-oriented, yet clinical assessment often remains centered on total body weight and BMI. Although BMI remains useful for screening and population-level risk stratification, it cannot characterize the biological heterogeneity of obesity or the...

26. 10. 2026 Read article →
Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m 2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial
overweight-obesity

Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m 2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial

Background Orforglipron, an oral small-molecule glucagon-like peptide-1 receptor agonist, improved body weight and cardiometabolic parameters in the phase 3 ATTAIN-1 trial, but its efficacy and safety in adults with body mass index (BMI) of ≥27 to 2 and adiposity-related complications have not been characterized....

14. 10. 2026 Read article →
Advertisement